ANDA 91307, held by Luitpold Pharmaceuticals. Metoprolol Tartrate.
As of Nov 22, 2026, ANDA 91307 (Metoprolol Tartrate), held by Luitpold Pharmaceuticals, was first approved by FDA on Dec 29, 2010, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 29, 2010 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metoprolol Tartrate1MG/ML · injectable;injection | Metoprolol Tartrate | Discontinued |
| Oct 21, 2019 | Supplement 2Labeling · Standard review | Approved | None posted |
| Dec 29, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters